Literature DB >> 22865915

Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production.

Anthony Gaba1, Sergei I Grivennikov, Mahn Vu Do, Deborah J Stumpo, Perry J Blackshear, Michael Karin.   

Abstract

In activated macrophages, the anti-inflammatory cytokine IL-10 inhibits expression of molecules that propagate inflammation in a manner that depends on transcription factor STAT3. Expression of IL-10 is regulated posttranscriptionally by the RNA-binding protein tristetraprolin (TTP), which destabilizes IL-10 mRNA in activated macrophages. Using LPS-activated bone marrow-derived murine macrophages, we demonstrate that TTP is a negative regulator of the IL-10/STAT3 anti-inflammatory response. LPS-stimulated TTP-deficient macrophages overproduced IL-10, contained increased amounts of activated STAT3, and showed reduced expression of inflammatory cytokines, including cytokines encoded by TTP target mRNAs. Thus, in LPS-stimulated TTP-deficient macrophages, increased IL-10/STAT3 anti-inflammatory control was dominant over the mRNA stabilization of specific TTP targets. The TTP gene promoter contains a conserved STAT3 binding site, and IL-10 induces STAT3 recruitment to this site. Correspondingly, STAT3 was required for efficient IL-10-induced TTP expression. Hence, by inducing TTP expression, STAT3 activates a negative regulatory loop that controls the IL-10/STAT3 anti-inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865915      PMCID: PMC3424405          DOI: 10.4049/jimmunol.1201126

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules.

Authors:  F Y Yue; R Dummer; R Geertsen; G Hofbauer; E Laine; S Manolio; G Burg
Journal:  Int J Cancer       Date:  1997-05-16       Impact factor: 7.396

2.  Inducible gene targeting in mice.

Authors:  R Kühn; F Schwenk; M Aguet; K Rajewsky
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

3.  Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10.

Authors:  C Y Brown; C A Lagnado; M A Vadas; G J Goodall
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

4.  Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.

Authors:  Lynn Williams; Laura Bradley; Alexandra Smith; Brian Foxwell
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin.

Authors:  W S Lai; M J Thompson; G A Taylor; Y Liu; P J Blackshear
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

7.  Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50.

Authors:  F Driessler; K Venstrom; R Sabat; K Asadullah; A J Schottelius
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

8.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10.

Authors:  C Bogdan; J Paik; Y Vodovotz; C Nathan
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

9.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

Authors:  G A Taylor; E Carballo; D M Lee; W S Lai; M J Thompson; D D Patel; D I Schenkman; G S Gilkeson; H E Broxmeyer; B F Haynes; P J Blackshear
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  38 in total

Review 1.  Significant roles played by IL-10 in Chlamydia infections.

Authors:  Hamid Hakimi; Mohammad Zare-Bidaki; Nahid Zainodini; Shokrollah Assar; Mohammad Kazemi Arababadi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 2.  An Ancient Family of RNA-Binding Proteins: Still Important!

Authors:  Melissa L Wells; Lalith Perera; Perry J Blackshear
Journal:  Trends Biochem Sci       Date:  2017-01-14       Impact factor: 13.807

Review 3.  The role of RNA-binding protein tristetraprolin in cancer and immunity.

Authors:  Jian Guo; Huiheng Qu; Ye Chen; Jiazeng Xia
Journal:  Med Oncol       Date:  2017-11-09       Impact factor: 3.064

4.  IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response.

Authors:  Biana Bernshtein; Caterina Curato; Marianna Ioannou; Christoph A Thaiss; Mor Gross-Vered; Masha Kolesnikov; Qian Wang; Eyal David; Louise Chappell-Maor; Alon Harmelin; Eran Elinav; Paresh Thakker; Venizelos Papayannopoulos; Steffen Jung
Journal:  Sci Immunol       Date:  2019-06-14

5.  Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner.

Authors:  Franz Kratochvill; Nina Gratz; Joseph E Qualls; Lee-Ann Van De Velde; Hongbo Chi; Pavel Kovarik; Peter J Murray
Journal:  Cancer Res       Date:  2015-07-16       Impact factor: 12.701

6.  MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop.

Authors:  Kirsty F MacKenzie; Mirjam W M Van Den Bosch; Shaista Naqvi; Suzanne E Elcombe; Victoria A McGuire; Alastair D Reith; Perry J Blackshear; Jonathan L E Dean; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

7.  A functional link between heme oxygenase-1 and tristetraprolin in the anti-inflammatory effects of nicotine.

Authors:  Md Jamal Uddin; Yeonsoo Joe; Min Zheng; Perry J Blackshear; Stefan W Ryter; Jeong Woo Park; Hun Taeg Chung
Journal:  Free Radic Biol Med       Date:  2013-10-02       Impact factor: 7.376

8.  Growth hormone prevents the development of autoimmune diabetes.

Authors:  Ricardo Villares; Dimitri Kakabadse; Yasmina Juarranz; Rosa P Gomariz; Carlos Martínez-A; Mario Mellado
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction.

Authors:  Peng Xu; Zongmei Wen; Xueyin Shi; Yuehua Li; Liyan Fan; Meng Xiang; Aijun Li; Melanie J Scott; Guozhi Xiao; Song Li; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

Review 10.  Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.

Authors:  Seth A Brooks; Perry J Blackshear
Journal:  Biochim Biophys Acta       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.